Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia.
Int J Mol Sci. 2019 Nov 10;20(22):5616. doi: 10.3390/ijms20225616.
Int J Mol Sci. 2019.
PMID: 31717629
Free PMC article.
Review.
Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models.
Muselli F, Mourgues L, Morcos R, Rochet N, Nebout M, Guerci-Bresler A, Faller DV, William RM, Mhaidly R, Verhoeyen E, Legros L, Peyron JF, Mary D.
Muselli F, et al.
Cancers (Basel). 2021 Apr 2;13(7):1693. doi: 10.3390/cancers13071693.
Cancers (Basel). 2021.
PMID: 33918475
Free PMC article.
Item in Clipboard
Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia.
Muselli F, Mourgues L, Rochet N, Nebout M, Guerci A, Verhoeyen E, Krug A, Legros L, Peyron JF, Mary D.
Muselli F, et al.
Cancers (Basel). 2023 Feb 3;15(3):995. doi: 10.3390/cancers15030995.
Cancers (Basel). 2023.
PMID: 36765952
Free PMC article.
Item in Clipboard
Cite
Cite